InsidersTradesSigma
Follow the 신흥 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 신흥 has logged 5 public disclosures. Market capitalisation: €128.9bn. The latest transaction was reported on 30 June 2026 (Other). Among the most active insiders: 이용익. All data is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
5 of 5 declarations
신흥 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market.